These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 21732703)

  • 1. The case for less, not more, US FDA regulation.
    Vernon JA; Golec JH
    Pharmacoeconomics; 2011 Aug; 29(8):637-40. PubMed ID: 21732703
    [No Abstract]   [Full Text] [Related]  

  • 2. US FDA Modernization Act, section 114: uses, opportunities and implications for comparative effectiveness research.
    Neumann PJ; Lin PJ; Hughes TE
    Pharmacoeconomics; 2011 Aug; 29(8):687-92. PubMed ID: 21732704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation--how much can the world afford? Are we getting value for money?
    Anisfeld MH
    J Pharm Sci Technol; 1994; 48(1):45-8. PubMed ID: 8004419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA recognition of first-world drug regulators as means of relieving U.S. drug shortages.
    Hunnisett-Dritz D
    Am J Health Syst Pharm; 2012 Oct; 69(19):1626, 1628. PubMed ID: 22997113
    [No Abstract]   [Full Text] [Related]  

  • 5. A perspective on US drug reimportation.
    Choudhry NK; Detsky AS
    JAMA; 2005 Jan; 293(3):358-62. PubMed ID: 15657329
    [No Abstract]   [Full Text] [Related]  

  • 6. Value for money of drug regulation.
    Bouvy JC; Koopmanschap MA; Schellekens H
    Expert Rev Pharmacoecon Outcomes Res; 2012 Jun; 12(3):247-9. PubMed ID: 22812545
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmaceutical Greed and Its Consequences.
    Jacobs HE
    Conn Med; 2016 May; 80(5):315-6. PubMed ID: 27328583
    [No Abstract]   [Full Text] [Related]  

  • 8. Why are we Being Overcharged for Pharmaceuticals? What Should We Do About It?
    Hyman DA; Silver C
    J Leg Med; 2019; 39(2):137-149. PubMed ID: 31503533
    [No Abstract]   [Full Text] [Related]  

  • 9. The FDA and the pharmaceutical industry: is regulation contributing to drug shortage?
    Roman A
    Albany Law Rev; 2013-2014; 77(2):539-77. PubMed ID: 24851322
    [No Abstract]   [Full Text] [Related]  

  • 10. Risks and benefits of importing prescription medications from lower-income countries.
    Dhalla IA; Detsky AS
    JAMA; 2008 Sep; 300(12):1453-5. PubMed ID: 18812537
    [No Abstract]   [Full Text] [Related]  

  • 11. Epidemiologic studies, warts and all, are our best chance.
    Hernán MA
    Epidemiology; 2011 Sep; 22(5):636-7. PubMed ID: 21811112
    [No Abstract]   [Full Text] [Related]  

  • 12. ASHP, other groups, advise FDA about solving counterfeit drug problems.
    Young D
    Am J Health Syst Pharm; 2003 Dec; 60(23):2406, 2408, 2411. PubMed ID: 14686215
    [No Abstract]   [Full Text] [Related]  

  • 13. The FDA and congress: differing agendas?
    Lipman AG
    J Pain Palliat Care Pharmacother; 2010 Jun; 24(2):116-7. PubMed ID: 20504131
    [No Abstract]   [Full Text] [Related]  

  • 14. Congress, the FDA, and the fair development of new medications for children.
    McKinney RE
    Pediatrics; 2003 Sep; 112(3 Pt 1):669-70. PubMed ID: 12949299
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA allows drug firms to distribute journal articles about unapproved uses.
    Tanne JH
    BMJ; 2009 Jan; 338():b187. PubMed ID: 19153126
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA chief attacks Canada's drug price controls.
    Webster P
    Lancet; 2003 Nov; 362(9398):1816. PubMed ID: 14661624
    [No Abstract]   [Full Text] [Related]  

  • 17. America's drug problem.
    Philpott S
    Hastings Cent Rep; 2012; 42(4):9-10. PubMed ID: 22777971
    [No Abstract]   [Full Text] [Related]  

  • 18. Drug shortages undergo more scrutiny by Congress.
    Thompson CA
    Am J Health Syst Pharm; 2012 Mar; 69(6):446, 448, 450. PubMed ID: 22382473
    [No Abstract]   [Full Text] [Related]  

  • 19. Pharmaceuticals and medical devices: business practices.
    ; Steiner DJ
    Issue Brief Health Policy Track Serv; 2014 Dec; ():1-38. PubMed ID: 25771555
    [No Abstract]   [Full Text] [Related]  

  • 20. Drug shortage crisis resolution.
    Duffy E
    J Pharm Pract; 2012 Dec; 25(6):619-20. PubMed ID: 23222856
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.